The effect of reperfusion therapy on cerebral blood flow in acute stroke

Journal of Stroke and Cerebrovascular Diseases

Volumn 8, Issue 1, 1999, Pages 9-16

  Rubin, Giorgio ^a   Firlik, Andrew D ^a   Pindzola, Ronda R ^a   Levy, Elad I ^a   Yonas, Howard ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Cerebral blood flow; Reperfusion therapy; Stroke; Xenon enhanced computed tomography

Indexed keywords

EID: 0002288557     PISSN: 10523057     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1052-3057(99)80033-0     Document Type: Article

References (38)

1. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N Engl J Med 333 (1995) 1581-1587
2. Hacke W., Kaste M., Fieschi C., et al. for the ECASS Study Group. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke: The European Cooperative Acute Stroke Study (ECASS). JAMA 274 (1995) 1017-1025
3. Mori E., Tabuchi M., Yoshida T., et al. Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery. Stroke 19 (1988) 802-812
4. Brott T.G., Haley Jr. E.C., Levy D.E., et al. Urgent therapy for stroke, I: Pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 23 (1992) 632-640
5. Haley Jr. E.C., Levy D.E., Brott T.G., et al. Urgent therapy for stroke, II: Pilot study of tissue plasminogen activator administered 91 to 180 minutes from onset. Stroke 23 (1992) 641-645
6. Sasaki O., Takeuchi S., Koike T., et al. Fibrinolytic therapy for acute embolic stroke: Intravenous, intracarotid, and intra-arterial local approaches. Neurosurgery 36 (1995) 246-253
7. Larrue V., von Kummer R., del Zoppo G., et al. Hemorrhagic transformation in acute ischemic stroke: Potential contributing factors in the European Cooperative Acute Stroke Study. Stroke 28 (1997) 957-960
8. Trouillas P., Nighoghossian N., Getenet J.C., et al. Open trial of intravenous tissue plasminogen activator in acute carotid territory stroke: Correlation of outcome with clinical and radiological data. Stroke 27 (1996) 882-890
9. Hossman K.A. Hemodynamics of postischemic reperfusion of the brain. In: Weinstein P.R., and Faden A.I. (Eds). Protection of the brain from ischemia (1990), Williams & Wilkins, Baltimore, MD 21-36
10. Davis A.J., and Jafar J.J. Hemorheology of cerebral blood flow and ischemia. In: Awad I.A. (Ed). Cerebrovascular occlusive disease and brain ischemia (1992), American Association of Neurological Surgeons, Park Ridge, IL 25-58
11. Ames A., Wright R.L., Kowada M., et al. Cerebral ischemia, II: The no-reflow phenomenon. Am J Pathol 52 (1968) 437-453
12. Hoedt-Rasmussen K., Skinhoj E., Paulson O., et al. Regional cerebral blood flow in acute apoplexy. Arch Neurol 17 (1967) 271-280
13. Fieschi C., Agnoli A., Battistini L., et al. Derangement of regional cerebral blood flow and of its regulatory mechanism in acute cerebrovascular lesions. Neurology 18 (1968) 1166-1179
14. Olsen T.S., and Lassen N.A. A dynamic concept of middle cerebral artery occlusion and cerebral infarction in the acute state based on interpreting severe hyperemia as a sign of embolic migration. Stroke 15 (1984) 458-467
15. Johnson D.W., Stringer W.A., Marks M.P., et al. Stable xenon CT cerebral blood flow imaging: Rationale for and role in clinical decision making. AJNR 12 (1991) 201-213
16. Yonas H., Pindzola R.R., and Johnson D.W. Xenon/computed tomography cerebral blood flow and its use in clinical management. Neurosurg Clin North Am 7 (1996) 605-616
17. Firlik A.D., Kaufmann A.M., Wechsler L.R., et al. Quantitative cerebral blood flow determinations in acute ischemic stroke: Relationship to computed tomography and angiography. Stroke 28 (1997) 2208-2213
18. Brott T.G., Adams H.P., Olinger C.P., et al. Measurement of acute cerebral infarction: A clinical examination scale. Stroke 20 (1989) 864-870
19. Kety S.S., and Schmidt C.F. The nitrous oxide method for the quantitative determination of cerebral blood flow in man: Theory, procedure, and normal values. J Clin Invest 27 (1948) 476-483
20. Gur D., Good W.F., Wolfson Jr. S.K., et al. In vivo mapping of local cerebral blood flow by xenon-enhanced computed tomography. Science 215 (1982) 1267-1268
21. Baird A.E., Donnan G.A., Austin M.C., et al. Reperfusion after thrombolytic therapy in ischemic stroke measured by single-photon emission computed tomography. Stroke 25 (1994) 79-85
22. Overgaard K., Sperling B., Boysen G., et al. Thrombolytic therapy in acute ischemic stroke: A Danish pilot study. Stroke 24 (1993) 1439-1446
23. von Kummer R., and Hacke W. Safety and efficacy of intravenous tissue plasminogen activator and heparin in acute middle cerebral artery stroke. Stroke 23 (1992) 646-652
24. Fieschi C., Argentino C., Lenzi G.L., et al. Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours. J Neurol Sci 91 (1989) 311-322
25. Herderschee D., Limburg M., van Royen E.A., et al. Thrombolysis with recombinant tissue plasminogen activator in acute ischemic stroke: Evaluation with rCBF-SPECT. Acta Neurol Scand 83 (1991) 317-322
26. Feeney D.M., and Baron J.C. Diaschisis. Stroke 17 (1986) 817-830
27. Wolpert S.M., Bruckmann H., Greenlee R., et al., rt-PA Acute Stroke Study Group. Neuroradiologic evaluation of patients with acute stroke treated with recombinant tissue plasminogen activator. AJNR 14 (1993) 3-13
28. Zeumer H., Freitag H.J., Zanella F., et al. Local intra-arterial fibrinolytic therapy in patients with stroke: Urokinase versus recombinant tissue plasminogen activator (r-TPA). Neuroradiology 35 (1993) 159-162
29. Dalal P.M. Cerebral embolism. Angiographic observation on spontaneous clot lysis. Lancet 1 (1965) 61-64
30. Fieschi C., and Bozzao L. Transient embolic occlusion of the middle cerebral artery and internal carotid arteries in cerebral apoplexy. J Neurol Neurosurg Psychiatry 32 (1969) 236-240
31. Zatz L.M., Iannone A.M., Eckman P.B., et al. Observations concerning intracerebral vascular occlusions. Neurology 15 (1965) 389-401
32. Hakim A.M., Evans A.C., Berger L., et al. The effect of nimodipine on the evolution of human cerebral infarction studied by PET. J Cereb Blood Flow Metab 9 (1989) 523-534
33. Marchal G., Serrati C., Rioux P., et al. PET imaging of cerebral perfusion and oxygen consumption in acute ischaemic stroke: Relation to outcome. Lancet 341 (1993) 925-927
34. Warach S., Dashe J.F., and Edelman R.R. Clinical outcome in ischemic stroke predicted by early diffusion-weighted and perfusion magnetic resonance imaging: A preliminary analysis. J Cereb Blood Flow Metab 16 (1996) 53-59
35. Hakim A.M., Pokrupa R.P., Villanueva J., et al. The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts. Ann Neurol 21 (1987) 279-289
36. Hughes R.L., Yonas H., Gur D., et al. Cerebral blood flow determination within the first 8 hours of cerebral infarction using stable xenon-enhanced computed tomography. Stroke 20 (1989) 754-760
37. Olsen T.S., Larsen B., Skriver B., et al. Focal cerebral hyperemia in acute stroke: Incidence, pathophysiology and clinical significance. Stroke 12 (1981) 598-607
38. Ringelstein E.B., Biniek R., Weiller C., et al. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 42 (1992) 289-298